Extract notice to the Minister

NB-Rivaroxaban

Common name / Subject : rivaroxaban
Name of the manufacturer : NB Pharma
Form :
Dosage :

Indication :

INESSS' Recommendation
Inscription (10 mg, 15 mg, 20 mg)
Inscription - Avec conditions (2,5 mg)

Minister's decisions
Surseoir à la décision

Evaluation published on August 14, 2025

Subscribe to our newsletter now

Subscription